Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.
Vette KM, Machalek DA, Gidding HF, Nicholson S, O'Sullivan MVN, Carlin JB, Downes M, Armstrong L, Beard FH, Dwyer DE, Gibb R, Gosbell IB, Hendry AJ, Higgins G, Hirani R, Hueston L, Irving DO, Quinn HE, Shilling H, Smith D, Kaldor JM, Macartney K. Vette KM, et al. Among authors: nicholson s. Open Forum Infect Dis. 2022 Jan 31;9(3):ofac002. doi: 10.1093/ofid/ofac002. eCollection 2022 Mar. Open Forum Infect Dis. 2022. PMID: 35169588 Free PMC article.
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
Nicholson S, Karapanagiotidis T, Khvorov A, Douros C, Mordant F, Bond K, Druce J, Williamson DA, Purcell D, Lewin SR, Sullivan S, Subbarao K, Catton M. Nicholson S, et al. Open Forum Infect Dis. 2021 May 10;8(7):ofab239. doi: 10.1093/ofid/ofab239. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34258311 Free PMC article.
Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year After Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence Studies.
Bailie CR, Tseng YY, Carolan L, Kirk MD, Nicholson S, Fox A, Sullivan SG. Bailie CR, et al. Among authors: nicholson s. Clin Infect Dis. 2022 Aug 24;75(1):e357-e360. doi: 10.1093/cid/ciac020. Clin Infect Dis. 2022. PMID: 35026841 Free PMC article.
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study.
Marsland MJ, Thomson TN, O'Brien HM, Peach E, Bellette J, Humphreys N, McKeon CA, Cross W, Moso MA, Batty M, Nicholson S, Karapanagiotidis T, Lim CK, Williamson DA, Winkler N, Koirala A, Macartney K, Glynn-Robinson A, Stewart T, Minko C, Snow KJ, Black J, Friedman ND. Marsland MJ, et al. Among authors: nicholson s. Med J Aust. 2024 May 27. doi: 10.5694/mja2.52344. Online ahead of print. Med J Aust. 2024. PMID: 38803004
Seropositivity and geographical distribution of Strongyloides stercoralis in Australia: A study of pathology laboratory data from 2012-2016.
Shield J, Braat S, Watts M, Robertson G, Beaman M, McLeod J, Baird RW, Hart J, Robson J, Lee R, McKessar S, Nicholson S, Mayer-Coverdale J, Biggs BA. Shield J, et al. Among authors: nicholson s. PLoS Negl Trop Dis. 2021 Mar 9;15(3):e0009160. doi: 10.1371/journal.pntd.0009160. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33690623 Free PMC article.
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.
Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP. Chappell KJ, et al. Among authors: nicholson s. Lancet Infect Dis. 2021 Oct;21(10):1383-1394. doi: 10.1016/S1473-3099(21)00200-0. Epub 2021 Apr 19. Lancet Infect Dis. 2021. PMID: 33887208 Free PMC article. Clinical Trial.
Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
Messina NL, Germano S, McElroy R, Rudraraju R, Bonnici R, Pittet LF, Neeland MR, Nicholson S, Subbarao K, Curtis N; BRACE trial. Messina NL, et al. Among authors: nicholson s. Clin Transl Immunology. 2022 Apr 22;11(4):e1387. doi: 10.1002/cti2.1387. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35573165 Free PMC article.
836 results